Institutional Ownership Lantern Pharma Inc. (LTRN)
This table provides information about the institutional ownership of Lantern Pharma Inc. (LTRN). We have compiled data on the 33 institutions that hold shares in the stock, with a total of 2.26 Million shares, which have been reported (via 13F filing form) to have a value of $7.83 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
601
shares
|
$2,085
0.0% of portfolio
|
Q2 2024
Reduced 0.17%
|
|
|
Northwestern Mutual Wealth Management CO
|
Nov 14, 2025 Q3 2025 |
500
shares
|
$1,735
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2025 Q3 2025 |
430
shares
|
$1,492
0.0% of portfolio
|
Q3 2025
Reduced 62.83%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 14, 2025 Q3 2025 |
215
shares
|
$746
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
6
shares
|
$20
0.0% of portfolio
|
Q3 2025
Reduced 92.21%
|
|
|
Key F Inancial Inc
|
Nov 05, 2025 Q3 2025 |
2
shares
|
$6
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|